Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Argos Therapeutics Inc.

www.argostherapeutics.com

Latest From Argos Therapeutics Inc.

Deal Watch: Roivant Spins Out Arvelle, Licenses Epilepsy Candidate From SK Biopharma

Already having launched several portfolio companies, Roivant goes a step further by spinning out CNS specialist Arvelle from Axovant. BI and IBM will incorporate blockchain technology in clinical trials, while AbbVie licenses multiple myeloma candidate from TeneoBio.

Business Strategies Commercial

Korean Firms Join Hands To Pick Up Troubled US Cancer Vaccine Firm Argos

Argos Therapeutics lands in the hands of Genexine and SCM Lifescience after the US immunotherapy firm was put up for sale by the Delaware bankruptcy court. The Korean biotechs plan to use the company’s cGMP facilities and experience in large US Phase III trials to accelerate their global market entry.

Deals South Korea

SOTIO's Dendritic Cell Vaccines Have Promise In Ovary And Lung Cancer

Interim Phase II data has shown that SOTIO's dendritic cell-based cancer vaccine candidates have efficacy in patients with ovarian cancer and non-small cell lung cancer.

Clinical Trials ImmunoOncology

ADAPT Or Die: Argos Therapeutics On Brink After Phase III Failure

The US firm brings in advisors as it considers its options after the Phase III ADAPT study of its cancer immunotherapy fails even after change to protocol.

Companies Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Merix Bioscience Inc.
  • Dendritix Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Argos Therapeutics Inc.
  • Senior Management
  • Contact Info
  • Argos Therapeutics Inc.
    Phone: (919) 287-6300
    4233 Technology Dr.
    Durham, NC 27704
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register